您的位置: 首页 > 农业专利 > 详情页

Diarilhidantina as the acceptor of androgeno
专利权人:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
JUNG, MICHAEL E.,YOO, DONGWON,SAWYERS, CHARLES L.,TRAN, CHRIS
申请号:
PE2012000638
公开号:
PE20121470A1
申请日:
2008.10.24
申请国别(地区):
PE
年份:
2012
代理人:
摘要:
1. A compound separated from sulfur dioxide (I), wherein R1 and R2 together contain 2-8 carbon atoms and are a single c1-8 tar group or a c1-8 tar group, which is replaced by a substitute selected from hydrogen Xi, bromine, fluorine, chlorine, etc.; R3 is h and thyroid; R4 is h, f, Cl, Br and I;R11 and R12 are independent h and methyl groups. (3.4) neos-an-5-il-2-fluorooffenil-2, 2-dimethyln-butylamine, etc. Except for a pharmaceutical composer This compound is an antigenic androgeno receptor that is useful in the treatment of hormonal prostate cancerSE REFIERE A UN COMPUESTO DERIVADO DE DIARILHIDANTOINA DE FORMULA (I) DONDE: R1 Y R2 JUNTOS COMPRENDEN DE 2-8 ATOMOS DE CARBONO Y SON INDEPENDIENTEMENTE UN GRUPO ALQUILO C1-8 O UN GRUPO ALQUILO C1-8 SUSTITUIDO CON UN SUSTIUYENTE SELECCIONADO DE HIDROXI, BROMO, FLUORO, CLORO, ENTRE OTROS; R3 ES H Y FORMILO; R4 ES H, F, Cl, Br Y I.; R11 Y R12 SON INDEPENDIENTEMENTE H Y METILO. SON COMPUESTOS PREFERIDOS: 4-(3-(4-(3-CIANOPROPIL)FENIL)-4,4-DIMETIL-5-OXO-2-TIOXO-IMIDAZOLIN-1-IL)-2-(TRIFLUOROMETIL)BENZONITRILO; 4-(8-OXO-5-(4-(4-OXOBUTIL)FENIL)-6-TIOXO-5,7-DIAZASPIRO[3.4]OCTAN-7-IL)-2-(TRIFLUOROMETIL)BENZONITRILO; 4-(4-(7-(4-CIANO-3-(TRIFLUOROMETIL)FENIL)-8-OXO-6-TIOXO-5,7-DIAZASPIRO[3.4]OCT-AN-5-IL)-2-FLUOROFENIL)-2,2-DIMETIL-N-METIBUTANAMIDA; ENTRE OTROS. REFERIDA ADEMAS A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES UN ANTAGONISTA DEL RECEPTOR DE ANDROGENO SIENDO UTIL EN EL TRATAMIENTO DE CANCER DE PROSTATA REFRACTARIO A LA HORMONA
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充